M3541 in Combination With Radiotherapy in Subjects With Solid Tumors

Investigator: Maen Abdelrahim, MD

Study Coordinator: Michelle Guthrie

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT03225105

Phone: 713.441.6564

Protocol Number: Pro00020822


This dose-escalation study will evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic, and explore antitumor activity of M3541 in combination with fractionated palliative radiotherapy (RT) in subjects with solid tumors with malignant lesions in the thorax, abdominal cavity, head and neck region, or extremities likely to benefit from palliative RT.
More to Explore
Live Chat Available